I am pleased to share that three companion papers have been published in the Journal of Antimicrobial Chemotherapy as part of the collaborative framework of COST Action CA21111 OneHealthdrugs.
Together, these articles present a strategic roadmap for the discovery and development of high-quality drug candidates against kinetoplastid diseases, covering the journey from initial compound identification to advanced drug development stages.
Read them here 👉 Part 1, Part 2, and Part 3
It was a pleasure to contribute to this international effort bringing together researchers from a wide range of disciplines and institutions. Congratulations to all co-authors on this achievement!